1. Home
  2. PCYO vs TTRX Comparison

PCYO vs TTRX Comparison

Compare PCYO & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

HOLD

Current Price

$11.43

Market Cap

249.5M

Sector

Utilities

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.84

Market Cap

285.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCYO
TTRX
Founded
1976
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.5M
285.1M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
PCYO
TTRX
Price
$11.43
$9.84
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
79.8K
46.1K
Earning Date
04-08-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
12.50
N/A
EPS
0.36
N/A
Revenue
$1,227,787.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.75
N/A
Revenue Growth
171.54
N/A
52 Week Low
$9.71
$2.57
52 Week High
$12.44
$11.69

Technical Indicators

Market Signals
Indicator
PCYO
TTRX
Relative Strength Index (RSI) 56.78 58.30
Support Level $10.51 $2.81
Resistance Level $11.65 $10.72
Average True Range (ATR) 0.30 0.62
MACD 0.01 -0.05
Stochastic Oscillator 48.95 55.41

Price Performance

Historical Comparison
PCYO
TTRX

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: